Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: “Real World” Data From Germany

Detalles Bibliográficos
Autores principales: Braitsch, Krischan, Schmalbrock, Laura K., Jung, Paul, Bumeder, Irmgard, Kiewe, Philipp, Hecker, Judith S., Verbeek, Mareike, Westermann, Jörg, Bullinger, Lars, Keller, Ulrich, Bassermann, Florian, Krönke, Jan, Götze, Katharina S., Rieger, Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365332/
https://www.ncbi.nlm.nih.gov/pubmed/35966764
http://dx.doi.org/10.1097/HS9.0000000000000759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365332/
https://www.ncbi.nlm.nih.gov/pubmed/35966764
http://dx.doi.org/10.1097/HS9.0000000000000759

Ejemplares similares